
Michael T. Jarratt MD
Principal Investigator, DermResearch, Inc, Austin, TX
Join to view full profile
8140 N Mopac ExpySte 3-130Austin, TX 78759
Phone+1 512-345-1350
Dr. Jarratt is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1969 - 1972
Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1966 - 1967
University of Texas Southwestern Medical SchoolClass of 1966
Certifications & Licensure
TX State Medical License 1966 - 2019
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
Publications & Presentations
PubMed
- 8 citationsPharmacokinetics of ingenol mebutate gel under maximum use conditions in large treatment areas.Alicia D. Bucko, Michael Jarratt, Dowling B Stough, Laerke Kyhl, John Villumsen
The Journal of Dermatological Treatment. 2018-01-02 - 9 citationsA-101, a Proprietary Topical Formulation of High-Concentration Hydrogen Peroxide Solution: A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the ...Janet Dubois, Michael Jarratt, Brian Beger, Mark Bradshaw, Christopher Powala
Dermatologic Surgery. 2017-09-01 - 5 citationsLack of significant anti-inflammatory activity with clindamycin in the treatment of rosacea: results of 2 randomized, vehicle-controlled trials.Philippe Martel, Michael Jarratt, Jonathan S. Weiss, Isabelle Carlavan
Cutis. 2017-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









